Retina Gallery ~ Full Sized Retina Images

Library of Free, Non-Copyrighted Retina Images and Videos

Choose your language:



55-year-old woman has had a vitreous hemorrhage in her left eye. She had one in the right eye in the past. The vision is clearing some as the blood absorbs. VISUAL ACUITY: OD 20/32, OS 20/40. IOP: OD 13, OS 12. The posterior chamber intraocular lens is in good position in both eyes. The left eye has a 1+ posterior capsular opacity. EXTENDED OPHTHALMOSCOPY: OD: Vertical C/D ratio is 0.3. There are patchy retinal hemorrhages. OS: Vertical C/D ratio is 0.3. There is neovascularization superotemporal to the macula, which is elevated into the vitreous and clearly under tension. There is a 2+ vitreous hemorrhage. FUNDUS PHOTOGRAPHY: The photos show the retinal hemorrhages in the right eye and the neovascularization in the left eye. FLUORESCEIN ANGIOGRAPHY: Fluorescein angiography shows moderate non perfusion in the periphery of the left eye with heavy leakage from the neovascularization. In the right eye there is some leakage from the microaneurysms in the macula and there is moderate non perfusion in the periphery. SPECTRALIS-SD-OCT SCAN: The OCT scan shows no significant retinal edema in either eye. IMPRESSION: 1. PROLIFERATIVE DIABETIC RETINOPATHY – LEFT EYE 2. VITREOUS HEMORRHAGE – LEFT EYE 3. BACKGROUND DIABETIC RETINOPATHY – RIGHT EYE 4. ABSORBING VITREOUS HEMORRHAGE – LEFT EYE DISCUSSION: I explained to the patient with pan retinal laser we can substantially reduce the risk of severe vision loss in the left eye. We talked about the risks, benefits, indications, and alternatives of panretinal photocoagulation and the patient agreed to this procedure after the questions were answered. Panretinal photocoagulation was performed today without difficulty.

pdros_lory_01.png
BDR OD with Macular Edema148 views00000
(0 votes)
pdros_lory_02.png
BDR OD with Macular Edema122 views00000
(0 votes)
pdros_lory_03.png
Neovascularization elsewhere (NVE) Left Eye with Vitreous Hemorrhage166 views00000
(0 votes)
pdros_lory_04.png
Neovascularization elsewhere (NVE) Left Eye with Vitreous Hemorrhage165 views00000
(0 votes)
pdros_lory_05.png
Neovascularization elsewhere (NVE) Left Eye with Vitreous Hemorrhage200 views00000
(0 votes)
pdros_lory_06.png
Neovascularization elsewhere (NVE) Left Eye with Vitreous Hemorrhage139 views00000
(0 votes)
pdros_lory_07.png
Neovascularization elsewhere (NVE) Left Eye with Vitreous Hemorrhage171 views00000
(0 votes)
pdros_lory_08.jpg
125 views00000
(0 votes)
pdros_lory_09.jpg
87 views00000
(0 votes)
pdros_lory_10.jpg
BDR FAF93 views00000
(0 votes)
pdros_lory_11.jpg
PDR - FAF116 views00000
(0 votes)
pdros_lory_12.jpg
PDR - IR99 views00000
(0 votes)
pdros_lory_13.jpg
Pre-proliferative Diabetic Retinopathy - Peripheral non-perfusion visible on FA138 views00000
(0 votes)
pdros_lory_14.jpg
Pre-proliferative Diabetic Retinopathy - Peripheral non-perfusion visible on FA81 views00000
(0 votes)
pdros_lory_15.jpg
Pre-proliferative Diabetic Retinopathy - Peripheral non-perfusion visible on FA94 views00000
(0 votes)
pdros_lory_16.jpg
Pre-proliferative Diabetic Retinopathy - Peripheral non-perfusion visible on FA111 views00000
(0 votes)
pdros_lory_17.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE104 views00000
(0 votes)
pdros_lory_18.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE94 views00000
(0 votes)
pdros_lory_19.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE107 views00000
(0 votes)
pdros_lory_20.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE142 views00000
(0 votes)
pdros_lory_21.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE102 views00000
(0 votes)
pdros_lory_22.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE108 views00000
(0 votes)
pdros_lory_23.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE97 views00000
(0 votes)
pdros_lory_24.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE104 views00000
(0 votes)
pdros_lory_25.jpg
Proliferative Diabetic Retinopathy and Vitreous Hemorrhage - FA shows leakage of dye from NVE111 views00000
(0 votes)
     
25 files on 1 page(s)

55-year-old woman has had a vitreous hemorrhage in her left eye. She had one in the right eye in the past. The vision is clearing some as the blood absorbs. VISUAL ACUITY: OD 20/32, OS 20/40. IOP: OD 13, OS 12. The posterior chamber intraocular lens is in good position in both eyes. The left eye has a 1+ posterior capsular opacity. EXTENDED OPHTHALMOSCOPY: OD: Vertical C/D ratio is 0.3. There are patchy retinal hemorrhages. OS: Vertical C/D ratio is 0.3. There is neovascularization superotemporal to the macula, which is elevated into the vitreous and clearly under tension. There is a 2+ vitreous hemorrhage. FUNDUS PHOTOGRAPHY: The photos show the retinal hemorrhages in the right eye and the neovascularization in the left eye. FLUORESCEIN ANGIOGRAPHY: Fluorescein angiography shows moderate non perfusion in the periphery of the left eye with heavy leakage from the neovascularization. In the right eye there is some leakage from the microaneurysms in the macula and there is moderate non perfusion in the periphery. SPECTRALIS-SD-OCT SCAN: The OCT scan shows no significant retinal edema in either eye. IMPRESSION: 1. PROLIFERATIVE DIABETIC RETINOPATHY – LEFT EYE 2. VITREOUS HEMORRHAGE – LEFT EYE 3. BACKGROUND DIABETIC RETINOPATHY – RIGHT EYE 4. ABSORBING VITREOUS HEMORRHAGE – LEFT EYE DISCUSSION: I explained to the patient with pan retinal laser we can substantially reduce the risk of severe vision loss in the left eye. We talked about the risks, benefits, indications, and alternatives of panretinal photocoagulation and the patient agreed to this procedure after the questions were answered. Panretinal photocoagulation was performed today without difficulty.